The present invention refers to antibodies, particularly to monoclonal antibodies, which bind to the extracellular domain of the AXL receptor tyrosine kinase and which at least partially inhibit AXL activity.
申请公布号
EP2918605(A1)
申请公布日期
2015.09.16
申请号
EP20150162381
申请日期
2008.11.12
申请人
U3 PHARMA GMBH
发明人
HETTMANN, THORE;NIEWÖHNER, JENS;RUHE, JENS;WIRTZ, PETER;SELLE, KERSTIN;ZWICK-WALLASCH, ESTHER;ROTHE, MIKE
